Personalized Medicines: Implications for Pharma
Published: | Updated:
Marketers will need to address not only the benefits of the therapy but also the benefits of a diagnostic assay.
Kathleen Dunn, KFDunn Life Sciences
Advertisement
Articles by Kathleen Dunn, KFDunn Life Sciences
Advertisement
Latest Updated Articles
Personalized Medicines: Implications for PharmaPublished: December 1st 2009 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Pharmaceutical Executive Daily: FDA Approves Hernexeos
5